close
This ad will auto close in 10 seconds

IAVI and CureVac partner to accelerate development and testing of AIDS vaccine candidates

Researchers at IAVI's Neutralizing Antibody Center at The Scripps Research Institute and elsewhere have designed several novel immunogens that have the potential to elicit such antibodies.